This story has been updated from a previous version to include comments from Bio-Rad's earnings call.

NEW YORK (GenomeWeb News) — Bio-Rad Laboratories reported after the close of the market today a 5 percent increase in fourth quarter revenues, driven by high-single-digit growth for its Life Science business.

The Hercules, Calif.-based company reported $602.6 million in revenues for the three months ended Dec. 31, 2013, up from $573.8 million a year ago, easily surpassing the average analyst estimate of $586.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.